Liver cancer research nurses in UK NHS hepatobiliary cancer MDT settings coordinate clinical trials spanning hepatocellular carcinoma, cholangiocarcinoma, hepatic metastases, TACE and TARE interventional procedures, sorafenib and lenvatinib targeted therapy, and atezolizumab plus bevacizumab immunotherapy — all generating dense PDF reading loads that are difficult to review on mobile devices. This guide explains how to convert those PDFs to EPUB for portable, reflowable reading.
| Source | Description | Format |
|---|---|---|
| NICE HCC Guidance | NICE guidance on hepatocellular carcinoma diagnosis and management | |
| BASL Liver Cancer Standards | British Association for the Study of the Liver liver cancer management standards | |
| NHS England Hepatobiliary Cancer Framework | Hepatobiliary cancer commissioning and quality standards | |
| EASL HCC Clinical Practice Guidelines | European Association for the Study of the Liver HCC clinical practice guidelines | |
| Journal of Hepatology / Hepatology Articles | Peer-reviewed liver cancer research on systemic therapy, TACE, TARE, and ablation outcomes |
| Step | Action | Tool |
|---|---|---|
| 1 | Download NICE/BASL guideline or trial protocol PDF | NICE website / BASL / sponsor portal |
| 2 | Upload to pdf2epub.toolkit.bot | Browser or API |
| 3 | Download converted EPUB | pdf2epub.toolkit.bot |
| 4 | Transfer to e-reader or reading app | Kindle / Kobo / Apple Books |
| 5 | Read and annotate during TACE waiting time, hepatobiliary MDT meetings, or travel between cancer centres | E-reader app highlights and notes |
Liver cancer research nurses coordinate complex trials across NICE hepatocellular carcinoma guidance, British Association for the Study of the Liver standards, NHS England hepatobiliary cancer commissioning frameworks, and Journal of Hepatology or Hepatology journal articles — all typically distributed as PDFs. Converting to EPUB enables reflowable text optimised for mobile reading between TACE/TARE procedure sessions, hepatobiliary MDT meetings, and participant consultations in UK NHS hepatobiliary cancer centres and cancer clinical trials units.
The most converted documents include NICE guidance on hepatocellular carcinoma, British Association for the Study of the Liver liver cancer management standards, NHS England hepatobiliary cancer commissioning frameworks, EASL clinical practice guidelines on HCC, and key articles from the Journal of Hepatology, Hepatology, and the Lancet Oncology covering sorafenib, lenvatinib, atezolizumab plus bevacizumab, TACE, TARE, and ablation for HCC, as well as gemcitabine-cisplatin for cholangiocarcinoma.
Yes. pdf2epub.toolkit.bot extracts structured content including BCLC staging algorithm tables, Child-Pugh scoring matrices, and treatment allocation flowcharts from NICE and EASL PDFs, rendering them as clean reflowable EPUB tables that remain readable on e-readers and mobile devices without horizontal scrolling.
Absolutely. UK liver cancer trials such as TOPAZ-1, KEYNOTE-966, IMbrave150, and TACE combination studies generate large protocol PDFs. pdf2epub.toolkit.bot converts these to EPUB files that can be read offline on Kindle, Kobo, or Apple Books during TACE procedure waiting time, home-working, or travel between NHS hepatobiliary cancer centres.
Yes. pdf2epub.toolkit.bot offers a free tier allowing liver cancer research nurses to convert documents up to 10 MB without an account, sufficient for most guideline PDFs and journal articles. Larger liver cancer trial protocol bundles benefit from the paid tier with batch processing and higher file size limits.